Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer
|臨床試驗位址||Markey Cancer Center|
|目前研究進度||This study has been completed.|
|試驗開始日期||February 8, 2005|
|試驗開始日期||April 4, 2017|
RATIONALE: Vaccines made from a person's white blood cells and allogeneic tumor cells may make the body build an effective immune response to kill tumor cells.
PURPOSE: This phase II trial is studying how well vaccine therapy works in treating patients with stage I, stage II, or stage III non-small cell lung cancer.